From Name

From Email

To Name

To Email

Message

New drug regimen cures more children with aggressive b-cell lymphoma

from National Cancer Institute

New drug regimen cures more children with aggressive b-cell lymphoma National Cancer Institute The results from a recent study establish a new standard for treating children and young adults newly diagnosed with fast-growing forms of B-cell non-Hodgkin lymphoma, including Burkitt lymphoma. In the study, adding the drug rituximab (Rituxan, Truxima) to standard chemotherapy improved the overall cure rate in these patients from approximately 87% to 95%. READ MORE

more